A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma (Q33378233)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma |
scientific article |
Statements
1 reference
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma (English)
1 reference
Pier Luigi Zinzani
1 reference
Michele Baccarani
1 reference
Monica Tani
1 reference
Stefano Fanti
1 reference
Vittorio Stefoni
1 reference
Alessio Perrotti
1 reference
Mariapaola Fina
1 reference
1 February 2008
1 reference
Identifiers
1 reference